Biopôle Clermont-Limagne
Technology park for life sciences
Year of creation : 2014
Statut : limited company
Size : 20
% of CA dedicated to R&D : N/A
Patents (number of) :

Contact details

Biopôle Clermont Limagne
Zone de la Varenne
Rue Henri et Gilberte Goudier
63200 Riom

Contact : Marc DELAUNAY
Phone : +33 546 284 567
Email :
Website :


Valbiotis is a Research & Development company committed to scientific innovation for the treatment and prevention of metabolic diseases in response to unmet medical needs.

Valbiotis has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of health nutrition products designed to reduce the risk of major metabolic diseases, based on a multi-target approach enabled by the use of plant-based ingredients.


The active substances of the pipeline, which are specific combinations of plant molecules called “TOTUM”, act simultaneously upon metabolic parameters to correct dysfunctions and halt their progression at the earliest stage of disease.


These four innovative active substances are intended for people at risk of developing type 2 diabetes, cardiovascular diseases, NASH (non-alcoholic steatohepatitis). Clinical development plans aim at obtaining specific health claim authorizations for each product from regulatory authorities such as the FDA (Food and Drug Administration in the United States), the EFSA (European Food Safety Authority in Europe) and other country-specific authorities.


The products are intended to be licensed to players in the health sector. In February 2020, the Company signed a first global strategic partnership ith Nestlé Health Science for the development and worldwide marketing of TOTUM•63, in the prediabetes market.


Created at the beginning of 2014 in La Rochelle, the Company has forged numerous partnerships with leading academic centers. The Company has 35 employees and has established three sites in France, including 2 R&D centers – Périgny, La Rochelle (17) and Riom (63) – and has a subsidiary in Quebec City (Canada).